HomeCAPR • NASDAQ
add
Capricor Therapeutics Inc
Previous close
$14.33
Day range
$14.08 - $14.61
Year range
$3.52 - $23.40
Market cap
651.58M USD
Avg Volume
951.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.26M | -63.44% |
Operating expense | 3.46M | 14.64% |
Net income | -12.56M | -96.49% |
Net profit margin | -555.20 | -437.41% |
Earnings per share | -0.38 | -53.66% |
EBITDA | -12.65M | -91.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 85.03M | 198.12% |
Total assets | 92.95M | 150.19% |
Total liabilities | 24.69M | -36.60% |
Total equity | 68.26M | — |
Shares outstanding | 45.47M | — |
Price to book | 8.48 | — |
Return on assets | -49.57% | — |
Return on capital | -78.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.56M | -96.49% |
Cash from operations | -11.64M | -32.38% |
Cash from investing | 2.00M | -74.04% |
Cash from financing | 67.33M | 30,353.48% |
Net change in cash | 57.69M | 6,867.31% |
Free cash flow | -7.27M | -43.81% |
About
CEO
Founded
2005
Website
Employees
102
